Digital Pathology During the COVID-19 Outbreak in Italy: Survey Study

Abstract

Background Transition to digital pathology usually takes months or years to be completed. We were familiarizing ourselves with digital pathology solutions at the time when the COVID-19 outbreak forced us to embark on an abrupt transition to digital pathology. Objective The aim of this study was to quantitatively describe how the abrupt transition to digital pathology might affect the quality of diagnoses, model possible causes by probabilistic modeling, and qualitatively gauge the perception of this abrupt transition. Methods A total of 17 pathologists and residents participated in this study; these participants reviewed 25 additional test cases from the archives and completed a final psychologic survey. For each case, participants performed several different diagnostic tasks, and their results were recorded and compared with the original diagnoses performed using the gold standard method (ie, conventional microscopy). We performed Bayesian data analysis with probabilistic modeling. Results The overall analysis, comprising 1345 different items, resulted in a 9% (117/1345) error rate in using digital slides. The task of differentiating a neoplastic process from a nonneoplastic one accounted for an error rate of 10.7% (42/392), whereas the distinction of a malignant process from a benign one accounted for an error rate of 4.2% (11/258). Apart from residents, senior pathologists generated most discrepancies (7.9%, 13/164). Our model showed that these differences among career levels persisted even after adjusting for other factors. Conclusions Our findings are in line with previous findings, emphasizing that the duration of transition (ie, lengthy or abrupt) might not influence the diagnostic performance. Moreover, our findings highlight that senior pathologists may be limited by a digital gap, which may negatively affect their performance with digital pathology. These results can guide the process of digital transition in the field of pathology.

Crossing the Andes: Challenges and opportunities for digital pathology in Latin America

“…Still, it was not a limiting factor in the diagnostic capacity, with no loss of accuracy. 34 , 35 , 36 …”

Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland

“… 4 Similar initiatives and recommendations were produced in Europe to try to maintain high-quality service and turnaround times during the pandemic. 13 In addition to its use in daily diagnostic practice, digital pathology also allowed effective communication and enhanced consultations, discussion and education among pathologists, which were all critical during this challenging time. 14 …”

Types and frequency of whole slide imaging scan failures in a clinical high throughput digital pathology scanning laboratory

“… 6 , 7 As the pathogen terraformed the global topography of clinical practice, shifting practitioner attitudes favoring WSI adoption for a litany of use cases lay in its wake. 5 , 7 , 8 , 9 , 10 A concurrently dynamic regulatory environment, e.g., US-government sanctioned “enforcement discretion” of CLIA regulations, allowed a restrictive laxity for remote sign out accelerating WSI adoption for primary diagnosis. 5 , 6 , 11 The US Food and Drug Administration (USFDA) granted clearance for medical marketing of the second WSI scanning system for primary diagnoses in surgical pathology following the Philips IntelliSite Pathology Solution™ in 2017 after affirming diagnostic concordance with glass slides and scanning reproducibility.…”